E-Submission
Yeungnam University College of MedicineIndexed in: ESCI, Scopus, PubMed,
PubMed Central, CAS, DOAJ, KCI
PubMed Central, CAS, DOAJ, KCI
FREE article processing charge
Search
- Page Path
- HOME > Search
Review article
- Optogenetic neuromodulation with gamma oscillation as a new strategy for Alzheimer disease: a narrative review
- Haneol Ko, Sang-Pil Yoon
- J Yeungnam Med Sci. 2022;39(4):269-277. Published online February 14, 2022
- DOI: https://doi.org/10.12701/jyms.2021.01683
- 4,038 View
- 122 Download
- 2 Web of Science
- 3 Crossref
-
Abstract
PDF - The amyloid hypothesis has been considered a major explanation of the pathogenesis of Alzheimer disease. However, failure of phase III clinical trials with anti-amyloid-beta monoclonal antibodies reveals the need for other therapeutic approaches to treat Alzheimer disease. Compared to its relatively short history, optogenetics has developed considerably. The expression of microbial opsins in cells using genetic engineering allows specific control of cell signals or molecules. The application of optogenetics to Alzheimer disease research or clinical approaches is increasing. When applied with gamma entrainment, optogenetic neuromodulation can improve Alzheimer disease symptoms. Although safety problems exist with optogenetics such as the use of viral vectors, this technique has great potential for use in Alzheimer disease. In this paper, we review the historical applications of optogenetic neuromodulation with gamma entrainment to investigate the mechanisms involved in Alzheimer disease and potential therapeutic strategies.
-
Citations
Citations to this article as recorded by
- Modulating Proteasome Function with Polyphenol Metabolites: A Promising Therapeutic Avenue for Alzheimer's Disease
Nyerovwo Charity Okei
European Journal of Medical and Health Research.2024; 2(2): 16. CrossRef - Exogenous AMPA downregulates gamma-frequency network oscillation in CA3 of rat hippocampal slices
Chengzhang Li, Zhenrong Li, Sihan Xu, Sanwei Jiang, Zhenli Ye, Bin Yu, Shixiang Gong, Junmei Li, Qilin Hu, Bingyan Feng, Mengmeng Wang, Chengbiao Lu
Scientific Reports.2023;[Epub] CrossRef - Light-Controlled Modulation and Analysis of Neuronal Functions
Carlo Matera, Piotr Bregestovski
International Journal of Molecular Sciences.2022; 23(21): 12921. CrossRef
- Modulating Proteasome Function with Polyphenol Metabolites: A Promising Therapeutic Avenue for Alzheimer's Disease
Case report
- Incidentally found cystic lymphangioma of the adrenal gland in an elderly male cadaver
- Hee Cheol Kim, Yunji Kang, Young Hee Maeng, Jinu Kim, Sang-Pil Yoon
- Yeungnam Univ J Med. 2019;36(3):265-268. Published online July 16, 2019
- DOI: https://doi.org/10.12701/yujm.2019.00262
- 5,565 View
- 63 Download
-
Abstract
PDF
- Adrenal cystic lymphangiomas are extremely rare entities that are often identified incidentally, with less than 60 cases reported to date. We found a protruding ovoid mass consisting of a multiloculated cystic lesion within right adrenal gland in the cadaver of a 75-year-old Korean man. The epithelial cells lining the adrenal cyst were diffusely positive for cluster of differentiation 31 and podoplanin, and negative for pan-cytokeratin. The histopathological diagnosis confirmed a cystic lymphangioma arising from the adrenal gland. Post-mortem findings of the present case are discussed based on the clinicopathological features of adrenal cystic lymphangiomas.
First
Prev
